Ardea Biosciences (RDEA) 8-K Financial statements and exhibits

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 29, 2003

IntraBiotics Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction
of incorporation) 000-29993
(Commission
File Number) 94-3200380
(IRS Employer
Identification No.)

2483 East Bayshore Road, Suite 100, Palo Alto, California
(Address of principal executive offices) 94303(Zip Code)

Registrant’s telephone number, including area code: (650) 526-6800

Not Applicable

(Former name or former address, if changed since last report)

TABLE OF CONTENTS

	Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
	Item 9. Regulation FD Disclosure (Information Provided under Item 12, Disclosure of Results of Operations and Financial Condition)
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1

Item 7. Financial Statements,Pro FormaFinancial Information and Exhibits.

(c) Exhibits

Number	Description
99.1	Press Release entitled “IntraBiotics Reports First Quarter 2003 Financial and Operating Results,” dated April 29, 2003.

Item 9. Regulation FD Disclosure (Information Provided under Item 12, Disclosure of Results of Operations and Financial Condition).

     Pursuant to the Securities and Exchange Commission Release No. 33-8216, dated March 27, 2003, the information provided herein is being furnished under Item 12 of Form 8-K.

     On April 29, 2003, IntraBiotics publicly disseminated a press release announcing certain financial results for the quarter ended March 31, 2003. A copy of the press release with respect to this matter is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	TELIK, INC.
Date: April 29, 2003	/s/ Eric H. Bjerkholt Eric H. Bjerkholt Sr. Vice President and Chief Financial Officer

EXHIBIT INDEX

Number	Description
99.1	Press Release entitled “IntraBiotics Reports First Quarter 2003 Financial and Operating Results,” dated April 29, 2003.